Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online April 6, 2007
Diabetes 56:1943-1947, 2007
DOI: 10.2337/db07-0055
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0055v1
db07-0055v2
56/7/1943    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loos, R. J.F.
Right arrow Articles by Wareham, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loos, R. J.F.
Right arrow Articles by Wareham, N. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Report

TCF7L2 Polymorphisms Modulate Proinsulin Levels and ß-Cell Function in a British Europid Population

Ruth J.F. Loos1, Paul W. Franks1,2, Richard W. Francis3, Inês Barroso4, Fiona M. Gribble3,5, David B. Savage5, Ken K. Ong1, Stephen O'Rahilly3,5, and Nicholas J. Wareham1

1 Medical Research Council Epidemiology Unit, Cambridge, U.K
2 Division of Medicine, Department of Public Health and Clinical Medicine, Umeå University Hospital, Umeå, Sweden
3 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, U.K
4 Metabolic Disease Group, The Wellcome Trust Sanger Institute, Hinxton, U.K
5 Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge, Cambridge, U.K

Address correspondence and reprint requests to Ruth Loos, PHD, MRC Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, U.K. E-mail: ruth.loos{at}mrc-epid.cam.ac.uk

Abbreviations: GLP-1, glucagon-like peptide 1; HOMA-S, homeostasis model assessment of insulin sensitivity; IGR, insulin-to-glucose ratio; OGTT, oral glucose tolerance test; SNP, single nucleotide polymorphism

Rapidly accumulating evidence shows that common T-cell transcription factor (TCF)7L2 polymorphisms confer risk of type 2 diabetes through unknown mechanisms. We examined the association between four TCF7L2 single nucleotide polymorphisms (SNPs), including rs7903146, and measures of insulin sensitivity and insulin secretion in 1,697 Europid men and women of the population-based MRC (Medical Research Council)-Ely study. The T-(minor) allele of rs7903146 was strongly and positively associated with fasting proinsulin (P = 4.55 x 10–9) and 32,33 split proinsulin (P = 1.72 x 10–4) relative to total insulin levels; i.e., differences between T/T and C/C homozygotes amounted to 21.9 and 18.4% respectively. Notably, the insulin-to-glucose ratio (IGR) at 30-min oral glucose tolerance test (OGTT), a frequently used surrogate of first-phase insulin secretion, was not associated with the TCF7L2 SNP (P > 0.7). However, the insulin response (IGR) at 60-min OGTT was significantly lower in T-allele carriers (P = 3.5 x 10–3). The T-allele was also associated with higher A1C concentrations (P = 1.2 x 10–2) and reduced ß-cell function, assessed by homeostasis model assessment of ß-cell function (P = 2.8 x 10–2). Similar results were obtained for the other TCF7L2 SNPs. Of note, both major genes involved in proinsulin processing (PC1, PC2) contain TCF-binding sites in their promoters. Our findings suggest that the TCF7L2 risk allele may predispose to type 2 diabetes by impairing ß-cell proinsulin processing. The risk allele increases proinsulin levels and diminishes the 60-min but not 30-min insulin response during OGTT. The strong association between the TCF7L2 risk allele and fasting proinsulin but not insulin levels is notable, as, in this unselected and largely normoglycemic population, external influences on ß-cell stress are unlikely to be major factors influencing the efficiency of proinsulin processing.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. C. Florez, A. K. Manning, J. Dupuis, J. McAteer, K. Irenze, L. Gianniny, D. B. Mirel, C. S. Fox, L. A. Cupples, and J. B. Meigs
A 100K Genome-Wide Association Scan for Diabetes and Related Traits in the Framingham Heart Study: Replication and Integration With Other Genome-Wide Datasets
Diabetes, December 1, 2007; 56(12): 3063 - 3074.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.